Table 3.
Epithelial ovarian cancer-specific mortality and all-cause mortality according to change in smoking from prediagnosis to postdiagnosis in the NHS and NHSII
Epithelial ovarian cancer-specific mortality |
All-cause mortality |
||||
---|---|---|---|---|---|
Total cases, n | Deaths, n | HR (95% CI) | Deaths, n | HR (95% CI) | |
Never smoker | 539 | 275 | 1.00 (ref) | 336 | 1.00 (ref) |
Former smoker | 433 | 255 | 1.20 (1.01,1.43) | 299 | 1.19 (1.01,1.40) |
Quit smoking after diagnosis | 43 | 22 | 0.84 (0.54,1.31) | 28 | 0.91 (0.62,1.35) |
Remained current smoker | 99 | 60 | 1.40 (1.05,1.87) | 74 | 1.43 (1.11,1.86) |
Never smoker is defined as being a never smoker at both prediagnosis and postdiagnosis assessments; Former smoker is defined as being a former smoker at both assessments; Quit smoking after diagnosis is defined as being a current smoker before diagnosis and former smoker after diagnosis; Remained current smoker is defined as being a current smoker at both assessments. Models adjusted for age and calendar year at diagnosis, tumor histologic subtype, stage, prediagnosis body mass index (BMI, categorical), change of BMI (categorical) and nonsteroidal anti-inflammatory drug usage from prediagnosis to postdiagnosis and cohort. Due to the small sample size, participants who reported past smoking before diagnosis and current smoking after diagnosis were excluded (n = 2).
Abbreviations: CI, confidence interval; HR, hazard ratio; NHS, Nurses’ Health Study; NHSII, Nurses’ Health Study II.
Bold values indicate p < 0.05.